From Medscape HIV/AIDS

Coverage from the

International AIDS Conference 2016

July 18 - 22, 2016; Durban, South Africa

July 18 - 22, 2016 Durban, South Africa
  • AIDS Long-Acting Injectable Antiretroviral Safe, Effective The first long-acting injectable antiretroviral regimen is safe and effective at 48 weeks, and patients find it very convenient, new research suggests.
  • AIDS HIV Vaccine Trial Gets Green Light Immune responses to candidate HIV vaccines in a South African population were so robust that a large phase 2b/3 efficacy trial will be launched.
  • AIDS Latest HIV Cure Data Expose Resilience of Infection Disappointing results from SEARCH 19 and other recent studies are a challenge for researchers, who must balance progress with the fact that most patients are doing well on antiretroviral therapy.

Conference News

Popular News from AIDS 2015

Medscape HIV/AIDS©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage